Authors: Sinclair, CJD Powell, AE Xiong, W LaRiviere, CG Baldwin, SA Cass, CE Young, JD Parkinson, FE

Citation: Cjd. Sinclair et al., Nucleoside transporter subtype expression: effects on potency of adenosinekinase inhibitors, BR J PHARM, 134(5), 2001, pp. 1037-1044

Authors: Sinclair, CJD Krizanac-Bengez, L Stanness, KA Janigro, D Parkinson, FE

Citation: Cjd. Sinclair et al., Adenosine permeation of a dynamic in vitro blood-brain barrier inhibited by dipyridamole, BRAIN RES, 898(1), 2001, pp. 122-125

Authors: Sinclair, CJD Geiger, JD

Citation: Cjd. Sinclair et Jd. Geiger, Caffeine use in sports - A pharmacological review, J SPORT MED, 40(1), 2000, pp. 71-79

Authors: Sinclair, CJD LaRiviere, CG Young, JD Cass, CE Baldwin, SA Parkinson, FE

Citation: Cjd. Sinclair et al., Purine uptake and release in rat C6 glioma cells: Nucleoside transport andpurine metabolism under ATP-depleting conditions, J NEUROCHEM, 75(4), 2000, pp. 1528-1538

Authors: Sinclair, CJD Shepel, PN Geiger, JD Parkinson, FE

Citation: Cjd. Sinclair et al., Stimulation of nucleoside efflux and inhibition of adenosine kinase by A(1) adenosine receptor activation, BIOCH PHARM, 59(5), 2000, pp. 477-483